BLBD vs NVRI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BLBD exhibits strong financial health with a Piotroski F-Score of 8/9, indicating robust operational and balance sheet strength. The company is growing rapidly, with 16.9% YoY revenue growth and 51.8% earnings growth, supported by improving margins and high returns on equity and assets. Despite a premium valuation relative to the Graham Number ($26.31) and elevated Price/Book ratio, the stock trades below the growth-based intrinsic value estimate of $113.28 and has a strong analyst consensus. However, recent insider selling activity presents a notable counter-signal to the otherwise positive fundamentals.
NVRI exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY EPS growth of -325%. Despite a speculative 186% price surge over the last year, the company is burdened by extreme leverage (Debt/Equity of 5.76) and negative profitability. The massive disconnect between the current price (near 52-week highs) and the underlying financial health suggests a speculative bubble rather than value creation. With stagnant revenue growth and consistent earnings misses, the risk of financial distress is elevated.
Compare Another Pair
Related Comparisons
BLBD vs NVRI: Head-to-Head Comparison
This page compares Blue Bird Corporation (BLBD) and Enviri Corporation (NVRI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.